ARTemis: A randomised trial of bevacizumab with neo-adjuvant chemotherapy for patients with HER2-negative early breast cancer
Authors: Earl, H.M., Hickish, T. et al.
Journal: CANCER RESEARCH
Volume: 75
eISSN: 1538-7445
ISSN: 0008-5472
DOI: 10.1158/1538-7445.SABCS14-PD2-3
Source: Web of Science (Lite)